Kairos Pharma, LTD. - Common Stock, par value $0.001 per share (KAPA) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2024 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
KAPA on NYSE
Shares outstanding
17,734,228
Price per share
$0.81
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
445,019
Total reported value
$505,843
% of total 13F portfolios
0%
Share change
+226,298
Value change
+$273,129
Number of holders
14
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Kairos Pharma, LTD. - Common Stock, par value $0.001 per share (KAPA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 5% -50% $628,306 -$576,510 884,938 -48% Armistice Capital, LLC 30 Jun 2025

As of 30 Sep 2025, 14 institutional investors reported holding 445,019 shares of Kairos Pharma, LTD. - Common Stock, par value $0.001 per share (KAPA). This represents 2.5% of the company’s total 17,734,228 outstanding shares.

Institutional Holders of Kairos Pharma, LTD. - Common Stock, par value $0.001 per share (KAPA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 445,019 $505,843 +$273,129 $1.17 14
2025 Q2 174,435 $123,288 -$1,296,527 $0.71 9
2025 Q1 1,577,246 $1,463,500 +$857,974 $0.94 8
2024 Q4 406,598 $618,272 +$548,969 $1.52 5
2024 Q3 45,320 $70,000 +$70,000 $1.53 2